You are here

NIH no longer recommends Eli Lilly or Regeneron monoclonal antibodies in its Covid-19 treatment guidelines

Primary tabs

Thu, 2022-01-20 17:14 — mike kraft

NIH no longer recommends Eli Lilly or Regeneron monoclonal antibodies in its Covid-19 treatment guidelines The National Institutes of Health Covid-19 treatment guidelines no longer recommend the use of two authorized monoclonal antibody treatments for patients with mild to moderate Covid-19 due to their diminished effectiveness against the Omicron variant. By <a href="/profiles/aditi-sandal">Aditi Sangal</a> and <a href="/profiles/adrienne-vogt">Adrienne Vogt</a>, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Page loaded in 0.460 seconds.